Skip to main content
. 2022 Oct 4;328(13):1326–1335. doi: 10.1001/jama.2022.16844

Table 3. Study Outcomes by Treatment Group.

Opioid-sparing protocol (n = 95) Standard care (n = 98) Difference (95% CI) P valuea
Difference
Total OMEs consumed, mg
Mean (95% CI) 8.4 (5.3-11.5) 72.6 (53.2 to 92.0) MD, 64.2 (44.4 to 84.0) <.001b
Median (IQR) 0 (0-8.0) 40.0 (7.5 to 105.0)
VAS score, mean (95% CI)c
2 wk 15.4 (11.3-19.5) 17.8 (13.9 to 21.7) MD, 2.7 (−3.0 to 8.4) .42d
6 wk 12.2 (8.3-16.1) 14.8 (11.3 to 18.3) MD, 2.6 (−2.7 to 7.9) .76
OMEs prescribed at discharge, mg
Mean (95% CI) 40.4 (39.6-41.2) 341.2 (310.2 to 372.2) MD, 300.8 (269.4 to 332.3) <.001
Median (IQR) 40 (40-40) 300 (300 to 450)
Patient-reported satisfaction at 6 wk, No. (%) OR, 1.2 (0.5 to 3.1) .90
Satisfied (always, usually) 79 (83.2) 79 (80.6)
Unsatisfied (sometimes, never) 9 (9.5) 11 (11.2)
Opioid refill requests completed, No. (%) 2 (2.1) 6 (6.2) OR, 3.07 (0.6 to 15.6) .16
Any adverse events, No. (%) 3 (3.2) 2 (2.1) OR, 0.65 (0.1 to 4.0) .63

Abbreviations: MD, mean difference; OR, odds ratio; OMEs; oral morphine equivalents; VAS, visual analog scale.

a

The t test was used for comparing means of continuous variables; Mann-Whitney U test, for medians of continuous variables; and the Pearson χ2test, for categorical variables.

b

Mann-Whitney U, z = −6.55.

c

Patients were instructed to draw a line on VAS scale (range, 0-100; 0, no pain; 100, the worst pain possible) to indicate their pain level.

d

t Test, t = .911.